评价不同治疗方案对多发性硬化的疗效及不良反应

目的:评价不同治疗方案对多发性硬化的疗效及不良反应;方法:通过随机方式将80例多发性硬化患者分成对照组和实验组,每组各40例,对照组患者采用常规方式进行治疗,实验组患者则在常规治疗的同时,给予β干扰素治疗;结果:实验组患者的临床治疗总有效率显著高于对照组患者(P<0.05);在不良反应发生率方面两组患者比较差异无统计学意义(P>0.05)。结论:在对多发性硬化进行治疗时,在常规治疗的基础上,给予β干扰素辅助治疗,能让临床治疗效果显著提高,安全可靠,具有临床推广价值。

Objective： evaluation of different treatment of multiple sclerosis of the efficacy and adverse reaction; Methods： through the random way the 80 cases of patients with multiple sclerosis is divided into control group and experimental group, each with 40 cases in each, control group were treated with routine treatment, patients in the experimental group is in the conventional treatment at the same time, giving interferon beta therapy. Results： the total efficiency of the clinical treatment of patients in the experimental group was significantly higher than that of the control group （P 〈 0.05） ; in adverse reactions occurred difference in rate of the patients of the two groups had no statistical significance （P〉 0.05）. Conclusion： in the treatment of multiple sclerosis, on the basis of conventional treatment, the treatment of interferon beta interferon can significantly improve the clinical treatment effect, safe and reliable, with clinical value.